Furthermore, statin inhibition of NF-κB activation and signaling reduces transcription of pro-angiogenic genes e.g., VEGFA, decreased tumor growth, increased tumor necrosis and apoptosis [221]. This evidence concerns the gene NFKB1 and neoplasm.